Literature DB >> 26006203

Seroprevalence of human fascioliasis in Van province, Turkey.

Zeynep Taş Cengiz1, Hasan Yılmaz, Ahmet Cumhur Dülger, Hayrettin Akdeniz, Mustafa Kasım Karahocagil, Mutalip Çiçek.   

Abstract

BACKGROUND/AIMS: Fasciola hepatica is a rare zoonotic parasite that infects the liver of many mammals including humans. The aim of this study was to determine the seroprevalence of fascioliasis in Van province by ELISA (antibody detection) on the assumption that not all cases could be detected by stool examination alone.
MATERIALS AND METHODS: A total of randomly selected 1,600 patients, directed from affiliated outpatient clinics to Yüzüncü Yıl University Medical Faculty Parasitology Laboratory, were enrolled in the study. Their mean age was 44.44±19.00 years. Blood samples were collected from all the patients, and their stool samples were examined. For the stool examination, native-lugol and sedimentation (in formalin-ethyl acetate) methods were employed. ELISA for F. hepatica was performed on the blood samples from all patients. Seropositive patients were treated with triclabendazole.
RESULTS: F. hepatica was detected by ELISA in 89 (5.6%) of the 1,600 patients, but eggs were identified on the stool examination in only 29 (1.8%) patients. The prevalence of F. hepatica was higher in females (7.2%) than in males (4.2%) and was higher in the ≥36-year age group (6.7%) than in the ≤35-year age group (4.4%). Abdominal pain (93.3%), fatigue (88.8%), and weight loss (69.7%) were the most common symptoms. Eosinophilia was present in 89.9% of the patients. All seropositive patients had a history of eating raw aquatic plants.
CONCLUSION: Stool examination alone is not sufficient to diagnose F. hepatica. Serological tests such as ELISA must be used together with stool examination.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26006203     DOI: 10.5152/tjg.2015.8001

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  4 in total

1.  Seroprevalence of fascioliasis in the eastern region of Turkey: an eight-year investigation.

Authors:  Yunus Emre Beyhan; Hasan Yılmaz
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

2.  Serological Study of Fascioliasis Using Indirect ELISA in Gorgan City, Golestan Province, Northern Iran.

Authors:  Negar Bahram; Mitra Sharbatkhori; Farideh Tohidi; Reza Ghasemikhah
Journal:  Iran J Parasitol       Date:  2020 Jul-Sep       Impact factor: 1.012

3.  Seroepidemiology of human fascioliasis and its relationship with anti-Fasciola IgG and liver enzymes as biomarkers of pathogenicity.

Authors:  Kiran Afshan; Saman Kabeer; Sabika Firasat; Sarwat Jahan; Mazhar Qayyum
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

4.  Multiple liver masses in a patient with breast cancer, metastasis or not? An unexpected diagnosis: hepatic fascioliasis. A case report and overview of the literature from Turkey.

Authors:  Çağri Damar; Arif Emre Emek; Hüseyin Uçar; Harun Erdal; Işik Conkbayir; Çiğdem Öztunali
Journal:  BJR Case Rep       Date:  2016-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.